These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Author: Kasamatsu T, Ohmi K, Takeuchi S, Takamizawa H, Matsuzawa M, Kawana T, Ueda K, Kubo H, Tsumuji Y, Kawashima Y.
    Journal: Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157.
    Abstract:
    Recombinant interferon alpha-2 (Sch 30500) was administered to 29 patients with advanced gynecological cancers (14 patients with cancer of the cervix, 8 with ovarian cancer, 4 with uterine sarcoma, 2 with endometrial cancer and 1 with unclassified cancer). No antitumor effects (CR and PR) were noted in 23 evaluable patients. Side effects observed were fever, tachycardia, diarrhea, chills, general fatigue, anorexia, nausea and vomiting. In some patients, leukopenia, decrease of hemoglobin and elevation of SGOT and SGPT were observed. No production of antibody for Sch 30500 was noted.
    [Abstract] [Full Text] [Related] [New Search]